Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system

被引:20
作者
Zhou, JW
Bradford, HF
机构
[1] Department of Biochemistry, Imp. Coll. Sci. Technol. and Med., London SW7 2AY, South Kensington
关键词
D O I
10.1016/S0301-0082(97)00030-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Determination of neurotransmitter phenotype in the peripheral nervous system (PNS) has been intensively characterized. However, relatively little is known about the underlying molecular and biochemical events involved in determination of transmitter phenotype in the central nervous system (CNS). It has been well established that nerve growth factors regulate cell growth and differentiation. They are increasingly recognized as playing an important role in many decision-making steps during development. Published data suggest that neurotransmitter phenotype is determined largely by exogenous stimuli, such as nerve growth factors-acidic/basic fibroblast growth factor, epidermal growth factor, neurotrophins, etc., working in concert with the genetic programmes. They exert potent effects independently or synergistically with other molecules by acting either on neural precursor cells or differentiated neuronal cells. However, the process of transmitter phenotype determination in the CNS is only beginning to be understood, with more uncharacterized substances, with considerable potency in this respect being reported and in need of isolation and Further study. These studies will bring great advances in our existing knowledge of brain development and have potential value for the development of new treatments for neurodegenerative diseases. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:27 / 43
页数:17
相关论文
共 104 条
  • [61] CONVERGENT REGULATION BY CILIARY NEUROTROPHIC FACTOR AND DOPAMINE OF TYROSINE-HYDROXYLASE EXPRESSION IN CULTURES OF RAT SUBSTANTIA-NIGRA
    MAGAL, E
    BURNHAM, P
    VARON, S
    LOUIS, JC
    [J]. NEUROSCIENCE, 1993, 52 (04) : 867 - 881
  • [62] DISRUPTION OF THE CNTF GENE RESULTS IN MOTOR-NEURON DEGENERATION
    MASU, Y
    WOLF, E
    HOLTMANN, B
    SENDTNER, M
    BREM, G
    THOENEN, H
    [J]. NATURE, 1993, 365 (6441) : 27 - 32
  • [63] Co-expression of tyrosine hydroxylase and glutamic acid decarboxylase in dopamine differentiation factor-treated striatal neurons in culture
    Max, SR
    Bossio, A
    Iacovitti, L
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1996, 91 (01): : 140 - 142
  • [64] MITOGENIC EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR ON EMBRYONIC VENTRAL MESENCEPHALIC DOPAMINERGIC NEURON PRECURSORS
    MAYER, E
    DUNNETT, SB
    FAWCETT, JW
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1993, 72 (02): : 253 - 258
  • [65] FGF MODULATES THE PDGF-DRIVEN PATHWAY OF OLIGODENDROCYTE DEVELOPMENT
    MCKINNON, RD
    MATSUI, T
    DUBOISDALCQ, M
    AARONSON, SA
    [J]. NEURON, 1990, 5 (05) : 603 - 614
  • [66] MCLEAN JH, 1988, J NEUROSCI, V8, P3658
  • [67] MILLER FD, 1994, PROGR BRAIN RES, V103, P24
  • [68] Mugnaini E., 1985, HDB CHEM NEUROANATOM, P436
  • [69] BDNF PROTEIN MEASURED BY A NOVEL ENZYME-IMMUNOASSAY IN NORMAL BRAIN AND AFTER SEIZURE - PARTIAL DISAGREEMENT WITH MESSENGER-RNA LEVELS
    NAWA, H
    CARNAHAN, J
    GALL, C
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1995, 7 (07) : 1527 - 1535
  • [70] RECOMBINANT CHOLINERGIC DIFFERENTIATION FACTOR (LEUKEMIA INHIBITORY FACTOR) REGULATES SYMPATHETIC NEURON PHENOTYPE BY ALTERATIONS IN THE SIZE AND AMOUNTS OF NEUROPEPTIDE MESSENGER-RNAS
    NAWA, H
    NAKANISHI, S
    PATTERSON, PH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (06) : 2147 - 2150